This study revealed that administration of rivastigmine and/or leflunomide in AlCl3-induced AD model in rats improved their spatial learning behavior, and significantly attenuated AChE activity and hippocampal pro-inflammatory cytokine release. Here, ACHE is linked to Alzheimer disease.